Session: S39-Reducing Health Disparities Through Clinical Trials
Room 104 (Moscone Center)
Since 2006, Dr. Alexander-Bridges and Loretta Doan the Societyís Associate Director of Science Policy, have worked together to 1) elicit the ideas of ENDOís constituency (academia, industry, government agencies and community research boards) about what impedes their efforts , 2) communicate these ideas using the Societyís websites and publications and 3) design strategies that the Society, working hand in hand with itís broad constituency might successfully undertake to intervene. This talk will review those efforts with emphasis on examples of what is missed when diverse populations are not included in trials that characterize disease markers and/or efficacy and safety of pharmacologic interventions.
See more of: Symposia